Parkinson’s disease: When molecular guardians need to be protected

Parkinson’s disease is the second most common, age-related, neurodegenerative disease: In Germany alone, about 300,000 people are affected and experience sometimes major limitations to their quality of life. Although Parkinson’s is so widespread, there is still no treatment that targets the cause of the disease and can stop it in its tracks. However, current research […]

Continue Reading